We demonstrate a simple, robust, and low-cost method for producing the PURE cell-free transcription-translation system. Our OnePot PURE system achieved a protein synthesis yield of 156 µg/mL at a cost of 0.09 USD/µL, leading to a 14-fold improvement in cost normalized protein synthesis yield over existing PURE systems. The OnePot method makes the PURE system easy to generate and allows it to be readily optimized and modified. * Correspondence: sebastian.maerkl@epfl.ch Cell-free transcription-translation systems have become popular for molecular engineering [1-6]. Cell-free systems can be categorized into two main classes: cell extract and recombinant systems. Cell extracts are highly functional but complex and undefined cell-free systems. In 2001, Shimizu et al. demonstrated that a defined cell-free system called the "PURE" system (protein synthesis using recombinant elements) could be reconstituted from purified recombinant components [7]. Because of its defined and minimal nature, PURE is an appealing choice for biological systems engineering. The PURE system has been used for genetic network engineering [2], recombinant DNA replication [8], molecular diagnostics [9], therapeutics [10], and educational kits [11]. The PURE system also represents a viable starting point for generation of an artificial cell [12, 13] and its composition has been optimized [14, 15] and extended [16] to achieve higher functionality.
the protein components led to only negligible changes in protein expression yield of the PURE system (data not shown). Additionally, over 50% of the HomeMade PURE protein components consists of EF-Tu ( Supplementary Table S5 ). Hence, we decided to optimize our OnePot PURE system with a particular focus on this translation factor.
We varied the relative volume of the EF-Tu inoculating culture with respect to the 35 remaining inoculation cultures to generate ratios of 3%, 17%, 38%, and 47%. The 3% ratio corresponds to 100 µL of all 36 inoculation cultures, including EF-Tu, being added to the mixed co-culture ( Supplementary Table S4 ). As can be seen from gels and corresponding analysis, larger percentages of the EF-Tu strain in the co-culture led to higher absolute levels of EF-Tu in the OnePot protein system ( Fig. 1b, Supplementary Fig. S2, S3 ). Increased concentrations of EF-Tu also gave rise to higher protein expression yields (Fig. 1c ). We could therefore show that it is possible to modify the ratio of an individual PURE protein component simply by varying the initial inoculation ratio of the corresponding strain, and that the OnePot PURE system gave rise to high protein expression yields.
It has been thought that precise control over the PURE system composition is required to achieve reproducible, and high protein expression yields and it has been suggested that a simple one-pot method would not be a viable option for robustly generating the PURE system [17] . However, we observed that variations in overnight culture densities (Supplementary Fig. S4 ) did not lead to substantial differences in OnePot PURE protein content ( Fig. 1d, Supplementary Fig. S2 ). We observed high protein expression robustness across four biological replicates, especially for the 38% and 47% EF-Tu formulations, with coefficients of variation (CV) of 8% and 12%, respectively (Fig. 1e, f) . In comparison, the CV for a technical replicate of PURExpress and HomeMade PURE were 5% and 12%, respectively.
To avoid significant total protein concentration differences across replicates, we adjusted the concentration of the protein mixture to 1.6 mg/mL in the final reaction. This optimal concentration was chosen based on titrations of OnePot PURE (47% EF-Tu) replicate A ( Supplementary Fig. S5 ).
We compared the protein composition of our OnePot PURE system to the commercially available PURExpress (NEB) and our HomeMade PURE system prepared based on the Shimizu protocol with minor adjustments [7] . From gels we determined that the overall composition of the PURExpress and HomeMade PURE systems were quite similar to one another as expected ( Fig. 2a ). Both PURExpress and HomeMade PURE had a higher relative percentage of EF-Tu and a lower total protein concentration (1 mg/mL for HomeMade PURE) than OnePot PURE. The relative intensities of individual proteins in the OnePot PURE deviated from the PURExpress and HomeMade PURE standards although the protein expression yield of the OnePot PURE system (47% EF-Tu) was similar to PURExpress, 1.6 times higher than our HomeMade PURE and 5 times higher than TraMOS (Fig. 2b) .
One of the main factors limiting the use of the PURE system is its high cost. We performed a detailed cost analysis of different PURE systems: two systems prepared from individually purified protein components (PURExpress and HomeMade PURE), as well as two systems prepared from batch cultures and pooled purifications (OnePot and TraMOS) ( Fig. 2c , Supplementary Table S1 [18, 20] . OnePot PURE substantially outperformed all other systems when directly comparing protein synthesis yield and cost per microliter ( Fig. 2d ) and achieved a cost normalized protein yield of 1.70 µg/USD compared to 0.27 µg/USD for HomeMade PURE, 0.12 µg/USD for PURExpress, and 0.03 µg/USD for TraMOS ( Fig. 2e ).
We demonstrated that it is possible to robustly produce a highly functional PURE system at low cost using a practical single batch culture and purification approach. The OnePot PURE system described here achieved a protein synthesis yield of 156 µg/mL at a cost of 0.09 USD/µL. At 1.7 µg/USD the cost normalized protein synthesis yield is over a magnitude higher than the commercial PURE system and substantially higher than TraMOS. We also showed that it is possible to adjust and optimize the OnePot PURE system by varying the inoculation fraction of an individual strain. This simple, low-cost, and robust protocol for producing the PURE system should broaden access to the technology and enable new applications which hitherto were not feasible due to the high cost and complexity of producing the PURE system.
MATERIALS AND METHODS
Escherichia coli strains and plasmids E. coli BL21(DE3) and M15 strains were used for protein expression. All plasmids encoding PURE proteins used in this work were originally obtained from Y. Shimizu (RIKEN Quantitative Biology Center, Japan). Genes coding for MK and PPiase were originally cloned in pET29b vectors with kanamycin resistance. To establish a OnePot system, we used CPEC assembly (Circular Polymerase Extension Cloning) [21] to clone a DNA fragment amplified from pET29b vectors containing MK and PPiase genes as well as the T7 promoter, RBS, and T7 terminator, into a pET21a vector containing ampicillin resistance. The primer sequences used are listed in Supplementary Table S7 . A list of the PURE proteins with their corresponding gene, vector and reference number are given in Supplementary Table S8 . E. coli A19 (Coli Genetic Stock Center, CGSC#: 5997) was used for ribosome purification.
The linear template DNA for in vitro eGFP synthesis was initially prepared by extension PCR from a pKT127 plasmid as described [2] and cloned into a pSBlue-1 plasmid. The DNA fragment used for PURE system characterization was amplified from this plasmid by PCR ( Supplementary Table S7 ) and purified by DNA Clean and Concentrator-25 (Zymo Research). DNA was eluted in nuclease-free water instead of elution buffer. For all reactions, a linear template from a single purification was used.
Buffers used for protein and ribosome purification
All buffers used in this work are listed in Supplementary Table S9 
Ribosome purification
Ribosomes were prepared from E. coli A19 by hydrophobic interaction chromatography (HIC) and sucrose cushion buffer ultracentrifugation as described previously with slight modifications [22, 23] . E. coli A19 strain was grown overnight in 100 mL of LB media at 37 • C. 2 × 30 mL of the overnight cultures was used to inoculate 2 × 2 L of LB. Cells were grown at 37 • C, 250 RPM to exponential phase (3-4 h, OD600 = 0.6-0. µM. The usual yield is above 0.75 mL of 10 µM ribosome solution.
SDS-PAGE gels
Proteins were separated by SDS-PAGE using 15-well 4-20% Mini-PROTEAN TGX Precast Protein Gels (Bio-Rad). Gels were stained using Bio-Safe Coomassie stain (Bio-Rad), scanned using an EPSON Perfection V10 scanner and analyzed with ImageJ.
Energy solution preparation
Energy solution was prepared as described previously with slight modifications [23] were determined from a standard curve ( Supplementary Fig. S7 ).
Cost calculations
To estimate the cost of PURE systems, we analyzed in detail the costs of the different subsets: protein components, ribosomes, and energy solution. The calculation for protein subset costs varies with the type of the system. For the TraMOS system, the reported cost of 0.052 USD/µL was used [17] . For our OnePot system, the cost was estimated based on the calculations given in Supplementary Table S1 , with the assumptions that some of the materials can be reused and that four purifications can be done simultaneously in one working day. In the case of the HomeMade PURE system, our estimate was based on the price charged by the EPFL protein expression core facility: 300 USD per 2 L expression culture, which corresponds to our calculation for OnePot PURE of 83 USD per 0.5 L culture (332 USD for 2 L, Supplementary Table S1 ). Although the total price of this PURE system is high, the total amount of proteins purified is higher as well which can generate at least 40 mL of PURE HomeMade system (based on the volume of the protein limiting the preparation, in our case EF-Tu). Therefore, the price per µL of HomeMade protein components is 0.27
USD.
Two different possibilities were taken into account in the case of the ribosome subset. In the first system, commercial ribosomes ( Supplementary Table S6 ) were used for the PURE reactions (TraMOS). In the second system, purified ribosomes were used (HomeMade and OnePot PURE). The cost calculations for purified ribosomes are given in Supplementary   Table S2 , with the assumptions that some of the materials can be reused and that hands-on time for one purification is a single working day.
The cost calculation for the OnePot energy solution is described in Supplementary Table   S3 , with the assumption that half a day is necessary for the preparation of 20 mL of energy solution. For the TraMOS energy solution and the additional protein components, the costs were recalculated based on the component's price that would apply for the preparation of the given solutions ( Supplementary Table S6 ). For some of the additional protein components, we were not able to determine the exact protein which was purchased and its amount used, mostly due to a difference in the type of units reported in the paper as compared to the units specified by the supplier. However, we arrived at a very similar cost estimate as given in the original calculation. Furthermore, we assumed that the work required for the solution preparation is taken into account in the purification cost calculation, so we did not consider it.
In the case of PURExpress, the total cost was based on the commercial price. The values used in the cost calculation were derived from experience with the actual experiments while preparing the different subsets. All costs for the different components were based on the prices given in our internal EPFL system when performing the calculation; no delivery costs were taken into account. 
